CD4 and cutaneous mastocytosis: The adoption of routine screening for cryptococcal infection among patients with a CD4 cell count below 100 cells/μl and pre-emptive therapy for cryptococcal meningitis will result in reduction of CM associated morbidity and mortality [30].